Your browser doesn't support javascript.
loading
Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
Unkart, Jonathan T; Proudfoot, James; Wallace, Anne M.
Affiliation
  • Unkart JT; Department of Surgery, Moores Cancer Center, University of California, San Diego, CA, USA.
  • Proudfoot J; Biostatistics Unit, Altman Clinical Translational Research Institute, University of California, San Diego, CA, USA.
  • Wallace AM; Department of Surgery, Moores Cancer Center, University of California, San Diego, CA, USA.
Breast J ; 24(4): 526-530, 2018 07.
Article in En | MEDLINE | ID: mdl-29498443
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Technetium Tc 99m Pentetate / Dextrans / Radiopharmaceuticals / Sentinel Lymph Node Biopsy / Sentinel Lymph Node / Mannans Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Technetium Tc 99m Pentetate / Dextrans / Radiopharmaceuticals / Sentinel Lymph Node Biopsy / Sentinel Lymph Node / Mannans Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States